Background: Distinguishing the unique immune microenvironment of left and right colorectal cancer (CRC) is essential for better the development of tailored therapeutic strategies and improving patient outcomes. However, few data
PDFPurpose: 73-year-old lady with a left moderately differentiated T1aN0MO estrogen positive, progesterone positive and non-overexpressing Her-2-neu infiltrating ductal carcinoma treated with mastectomy and adjuvant anastrozole who reported left upper abdominal discomfort.
PDF